Products

Fetal Bovine Serum (Exosome Depleted)

As intercellular communication and exosome research become key focal points in modern biomedical science, bovine exosomes natively present in conventional fetal bovine serum often create substantial background noise during data analysis.

TADS Exosome Depleted FBS utilizes advanced ultracentrifugation and proprietary membrane filtration techniques to reduce exosome residual levels to less than 3%, while fully preserving essential growth factors, natural hormones, and nutrients required for optimal cell growth.

No. Size Price Qty
50 ml -
The price does not include shipping fee and tax. ORDER

Processed and manufactured in state-of-the-art facilities in the United States, TADS Exosome-Depleted FBS undergoes rigorous triple 0.1 µm membrane sterile filtration. Utilizing proprietary depletion technology, it reduces bovine exosome residuals to < 3% while overcoming the traditional technical bottleneck of damaging essential serum nutrients. Biological activity testing confirms a cell growth rate of > 80%, ensuring cells maintain optimal growth momentum.


Product Highlights:

  • Low Endotoxin:≤ 5 EU/mL, minimizing potential cellular interference to ensure authentic biological performance.
  • Low Hemoglobin:≤ 20 mg/dL, effectively enhancing experimental reproducibility and data stability.
  • Triple 0.1 µm Sterile Filtration:High-specification aseptic processing prevents microbial contamination and creates a safe culture environment.
  • Exosome Residual:< 3%, thoroughly eliminating bovine exosome background interference for precise cell signaling research.



Core Advantages:

  • Batch Consistency:Precise control over endotoxin and hemoglobin levels ensures high data reproducibility across different lots.
  • Cell Performance:Verified to maintain high-activity performance (> 80%) for both plating efficiency and passage growth.
  • Quality Assurance:Every lot is tested for mycoplasma, certified free of bacterial and fungal growth, and thoroughly screened for 12 bovine viruses (including BVD, IBR, and BRSV) to ensure laboratory biosafety.
  • Exosome Interference:Residual exosomes < 3% ensure detected exosomes originate strictly from target cells, eliminating the hassle and yield loss of manual ultracentrifugation.